197 related articles for article (PubMed ID: 7759480)
1. Inhibition of protein tyrosine phosphorylation in T cells by a novel immunosuppressive agent, leflunomide.
Xu X; Williams JW; Bremer EG; Finnegan A; Chong AS
J Biol Chem; 1995 May; 270(21):12398-403. PubMed ID: 7759480
[TBL] [Abstract][Full Text] [Related]
2. CD5 acts as a tyrosine kinase substrate within a receptor complex comprising T-cell receptor zeta chain/CD3 and protein-tyrosine kinases p56lck and p59fyn.
Burgess KE; Yamamoto M; Prasad KV; Rudd CE
Proc Natl Acad Sci U S A; 1992 Oct; 89(19):9311-5. PubMed ID: 1384049
[TBL] [Abstract][Full Text] [Related]
3. 7,12-Dimethylbenz[a]anthracene activates protein-tyrosine kinases Fyn and Lck in the HPB-ALL human T-cell line and increases tyrosine phosphorylation of phospholipase C-gamma 1, formation of inositol 1,4,5-trisphosphate, and mobilization of intracellular calcium.
Archuleta MM; Schieven GL; Ledbetter JA; Deanin GG; Burchiel SW
Proc Natl Acad Sci U S A; 1993 Jul; 90(13):6105-9. PubMed ID: 8327490
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of TCR/CD3-mediated signaling by a mutant of the hematopoietically expressed G16 GTP-binding protein.
Zhou J; Stanners J; Kabouridis P; Han H; Tsoukas CD
Eur J Immunol; 1998 May; 28(5):1645-55. PubMed ID: 9603471
[TBL] [Abstract][Full Text] [Related]
5. CD3-zeta surface expression is required for CD4-p56lck-mediated upregulation of T cell antigen receptor-CD3 signaling in T cells.
Sancho J; Ledbetter JA; Choi MS; Kanner SB; Deans JP; Terhorst C
J Biol Chem; 1992 Apr; 267(11):7871-9. PubMed ID: 1532798
[TBL] [Abstract][Full Text] [Related]
6. Characterization of p59fyn-mediated signal transduction on T cell activation.
Fusaki N; Semba K; Katagiri T; Suzuki G; Matsuda S; Yamamoto T
Int Immunol; 1994 Aug; 6(8):1245-55. PubMed ID: 7981151
[TBL] [Abstract][Full Text] [Related]
7. Increase in the specific activity of p50csk in proliferating T cells correlates with decreased specific activity of p56lck and p59fyn and reduced phosphorylation of CD3 subunits.
Orchansky PL; Ng DH; Johnson P; Teh HS
Mol Immunol; 1996 Apr; 33(6):531-40. PubMed ID: 8700169
[TBL] [Abstract][Full Text] [Related]
8. TGF-beta abrogates TCR-mediated signaling by upregulating tyrosine phosphatases in T cells.
Choudhry MA; Sir O; Sayeed MM
Shock; 2001 Mar; 15(3):193-9. PubMed ID: 11236902
[TBL] [Abstract][Full Text] [Related]
9. T cell-specific adapter protein inhibits T cell activation by modulating Lck activity.
Sundvold V; Torgersen KM; Post NH; Marti F; King PD; Røttingen JA; Spurkland A; Lea T
J Immunol; 2000 Sep; 165(6):2927-31. PubMed ID: 10975797
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of the antiproliferative action of leflunomide. A77 1726, the active metabolite of leflunomide, does not block T-cell receptor-mediated signal transduction but its antiproliferative effects are antagonized by pyrimidine nucleosides.
Cao WW; Kao PN; Chao AC; Gardner P; Ng J; Morris RE
J Heart Lung Transplant; 1995; 14(6 Pt 1):1016-30. PubMed ID: 8719445
[TBL] [Abstract][Full Text] [Related]
11. Age-related impairments in TCR/CD3 activation of ZAP-70 are associated with reduced tyrosine phosphorylations of zeta-chains and p59fyn/p56lck in human T cells.
Whisler RL; Chen M; Liu B; Newhouse YG
Mech Ageing Dev; 1999 Nov; 111(1):49-66. PubMed ID: 10576607
[TBL] [Abstract][Full Text] [Related]
12. Age-related impairment of p56lck and ZAP-70 activities in human T lymphocytes activated through the TcR/CD3 complex.
Fülöp T; Gagné D; Goulet AC; Desgeorges S; Lacombe G; Arcand M; Dupuis G
Exp Gerontol; 1999 Apr; 34(2):197-216. PubMed ID: 10363787
[TBL] [Abstract][Full Text] [Related]
13. Two activities of the immunosuppressive metabolite of leflunomide, A77 1726. Inhibition of pyrimidine nucleotide synthesis and protein tyrosine phosphorylation.
Xu X; Williams JW; Gong H; Finnegan A; Chong AS
Biochem Pharmacol; 1996 Aug; 52(4):527-34. PubMed ID: 8759024
[TBL] [Abstract][Full Text] [Related]
14. T cell receptor zeta/CD3-p59fyn(T)-associated p120/130 binds to the SH2 domain of p59fyn(T).
da Silva AJ; Janssen O; Rudd CE
J Exp Med; 1993 Dec; 178(6):2107-13. PubMed ID: 7504057
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the T-cell receptor-mediated signal transduction by microinjection of anti-Lck monoclonal antibody into T-cells.
Nakamura K; Koga Y; Yoshida H; Tanaka K; Sasaki M; Kimura G; Nomoto K
Biochim Biophys Acta; 1994 Dec; 1224(3):495-505. PubMed ID: 7803509
[TBL] [Abstract][Full Text] [Related]
16. T cells infiltrating non-Hodgkin's B cell lymphomas show altered tyrosine phosphorylation pattern even though T cell receptor/CD3-associated kinases are present.
Wang Q; Stanley J; Kudoh S; Myles J; Kolenko V; Yi T; Tubbs R; Bukowski R; Finke J
J Immunol; 1995 Aug; 155(3):1382-92. PubMed ID: 7636203
[TBL] [Abstract][Full Text] [Related]
17. The CD45 tyrosine phosphatase regulates specific pools of antigen receptor-associated p59fyn and CD4-associated p56lck tyrosine in human T-cells.
Biffen M; McMichael-Phillips D; Larson T; Venkitaraman A; Alexander D
EMBO J; 1994 Apr; 13(8):1920-9. PubMed ID: 8168490
[TBL] [Abstract][Full Text] [Related]
18. Stimulatory effects of the protein tyrosine phosphatase inhibitor, pervanadate, on T-cell activation events.
Secrist JP; Burns LA; Karnitz L; Koretzky GA; Abraham RT
J Biol Chem; 1993 Mar; 268(8):5886-93. PubMed ID: 8383678
[TBL] [Abstract][Full Text] [Related]
19. Costimulation with dexamethasone and prostaglandin E2: a novel paradigm for the induction of T-cell anergy.
Elliott LH; Levay AK
Cell Immunol; 1997 Sep; 180(2):124-31. PubMed ID: 9341742
[TBL] [Abstract][Full Text] [Related]
20. CD50 (intercellular adhesion molecule 3) stimulation induces calcium mobilization and tyrosine phosphorylation through p59fyn and p56lck in Jurkat T cell line.
Juan M; Viñas O; Pino-Otín MR; Places L; Martínez-Cáceres E; Barceló JJ; Miralles A; Vilella R; de la Fuente MA; Vives J
J Exp Med; 1994 Jun; 179(6):1747-56. PubMed ID: 7515097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
